| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/03/2011 | CA2769677A1 Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| 02/03/2011 | CA2769633A1 Crystallization method and bioavailability |
| 02/03/2011 | CA2769625A1 Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| 02/03/2011 | CA2769582A1 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | CA2769540A1 Long acting insulin composition |
| 02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | CA2769477A1 Pharmaceutical formulation |
| 02/03/2011 | CA2769340A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | CA2769258A1 Modified factor ix polypeptides and uses thereof |
| 02/03/2011 | CA2769247A1 Solutions comprising polyethylene glycol and electrolytes |
| 02/03/2011 | CA2769244A1 Glycopolysialylation of non-blood coagulation proteins |
| 02/03/2011 | CA2769223A1 Sticky soft gel for treating poultry |
| 02/03/2011 | CA2769177A1 Tablet |
| 02/03/2011 | CA2769162A1 Biodegradable polyethylene glycol based water-insoluble hydrogels |
| 02/03/2011 | CA2769152A1 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer |
| 02/03/2011 | CA2769011A1 Vaccine stabilizer |
| 02/03/2011 | CA2769008A1 A pharmaceutical composition for an iontophoresis |
| 02/03/2011 | CA2768586A1 Dermal formulations of dp2 receptor antagonists |
| 02/03/2011 | CA2767976A1 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 02/03/2011 | CA2762366A1 H. pylori lipopolysaccharide outer core epitope |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280024A2 Polypeptide specifically coupled to phosphatidylserine and use thereof |
| 02/02/2011 | EP2280021A1 Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2280020A1 Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| 02/02/2011 | EP2280004A1 Pharmaceutique formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2279778A1 Storage-stable compositions of glycerol monoalkyl ethers |
| 02/02/2011 | EP2279758A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279756A2 Method for shielding functional sites or epitopes on proteins |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279752A2 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279739A1 Donepezil-containing patch preparation and packaging thereof |
| 02/02/2011 | EP2279731A1 Improved pharmaceutical composition containing ibuprofen and codeine |
| 02/02/2011 | EP2279254A1 Novel lipid formulations for nucleic acid delivery |
| 02/02/2011 | EP2279008A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 02/02/2011 | EP2279007A2 Pegylated recombinant human growth hormone compounds |
| 02/02/2011 | EP2279006A1 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| 02/02/2011 | EP2279005A1 Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
| 02/02/2011 | EP2278999A2 Auris formulations for treating otic diseases and conditions |
| 02/02/2011 | EP2278981A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 02/02/2011 | EP2278956A1 Antiviral formulation |
| 02/02/2011 | EP2278955A1 Pharmaceutical composition and diagnostic and therapeutic use thereof |
| 02/02/2011 | EP2278954A1 Polymeric artificial tear system |
| 02/02/2011 | EP2278953A2 Self-preserved emulsions |
| 02/02/2011 | EP2278890A1 Compositions of phytosterols with enhanced bioavailability |
| 02/02/2011 | EP1682491B1 Non-symmetrical gelling agent |
| 02/02/2011 | EP1539976B1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 02/02/2011 | EP1511471B1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same |
| 02/02/2011 | CN1965836B Oral solid formulation and its preparation method |
| 02/02/2011 | CN1927195B Film agent comprising sodium gualenate using for eyes |
| 02/02/2011 | CN1849114B Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 02/02/2011 | CN101965366A Immunoconjugates targeting cd138 and uses thereof |
| 02/02/2011 | CN101965201A Intralymphatic chemotherapy drug carriers |
| 02/02/2011 | CN101965200A Conjugated factor viii molecules |
| 02/02/2011 | CN101965199A Selenium containing modifying agents and conjugates |
| 02/02/2011 | CN101965198A Improved fibronectin-based binding molecules and their use |
| 02/02/2011 | CN101965181A Timed-release pharmaceutical preparation |
| 02/02/2011 | CN101962596A Method for synchronously preparing walnut oil and walnut peptide |
| 02/02/2011 | CN101962464A Method for preparing calcium alginate microspheres with temperature response performance |
| 02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
| 02/02/2011 | CN101962319A Synthetic micromolecule compound capable of conveying bioactive substances and application thereof |
| 02/02/2011 | CN101961496A Cancerous disease modifying antibodies |
| 02/02/2011 | CN101961495A Plant soft capsule material and preparation method thereof |
| 02/02/2011 | CN101961494A Star polymer nano-medicament carrier preparation used for intracellular medicament delivery and preparation method thereof |
| 02/02/2011 | CN101961418A Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch |
| 02/02/2011 | CN101961403A Combined Chinese medicinal ointment for treating hemorrhoids |
| 02/02/2011 | CN101961352A Self-emulsified fish oil soft capsules without fishy smell |
| 02/02/2011 | CN101961335A Enrofloxacin hexahydrate-containing composition and application thereof in preparing medicament for treating or preventing poultry diseases |
| 02/02/2011 | CN101961324A Prescription and preparation method of etofbrate release capsules |
| 02/02/2011 | CN101961323A Self-emulsified resveratrol soft capsules |
| 02/02/2011 | CN101961322A Medicinal composition for treating hyperlipidaemia |
| 02/02/2011 | CN101961321A Zinc gluconate sugar tablet preparation and preparation method thereof |
| 02/02/2011 | CN101961320A Budesonide nano crystallizing preparation and preparation method thereof |
| 02/02/2011 | CN101961317A Controlled agglomeration |
| 02/02/2011 | CN101961316A LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof |
| 02/02/2011 | CN101961315A Ornithine aspartate liposome injection |
| 02/02/2011 | CN101961314A Novel nanoemulsion drug loading system for protein drugs and preparation method thereof |
| 02/02/2011 | CN101961313A Itraconazole nanocrystals and preparation method and application thereof |
| 02/02/2011 | CN101961312A Lipoid acid composition for injection |
| 02/02/2011 | CN101961311A 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof |
| 02/02/2011 | CN101961307A Oral liquid for treating respiratory disease and preparation method thereof |
| 02/02/2011 | CN101961306A Preparation method of low melting point drug solid dispersion |
| 02/02/2011 | CN101716153B Ornidazole ester microsphere solid preparation |
| 02/02/2011 | CN101669899B Sustained-release implant taking maize protein as main framework material or matrix and use thereof |
| 02/02/2011 | CN101653413B Tacrolimus ophthalmic emulsion and its preparation method |
| 02/02/2011 | CN101623262B Cephazolin sodium pentahydrate proliposome preparation |
| 02/02/2011 | CN101623258B Ranitidine hydrochloride lipidosome capsule and new application thereof |
| 02/02/2011 | CN101612138B Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
| 02/02/2011 | CN101596177B Coenzyme Q10 self-emulsifying composition, preparation method and application thereof |
| 02/02/2011 | CN101585920B Method for preparing poly(pseudo)rotaxanes with gamma-cyclodextrin and polyvinyl alcohol |
| 02/02/2011 | CN101491535B Method for preparing azithromycin composition with reduced bitter |
| 02/02/2011 | CN101491500B Meglumine adenosine cyclphosphate microspheres and production method thereof |
| 02/02/2011 | CN101468023B Exemestane tablet and technique for preparing the same |
| 02/02/2011 | CN101444503B Efficient long-acting silibinin preparation and preparation method thereof |
| 02/02/2011 | CN101380375B External traditional Chinese medicine preparation for treating bone and soft tissue injury and preparation method thereof |
| 02/02/2011 | CN101361763B Pollen hormone freeze dehydration method |